In: Accounting
Problem 16-5
Amy Dyken, controller at Ivanhoe Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Ivanhoe’s financial statements. Below is selected financial information for the fiscal year ended June 30, 2017.
IVANHOE PHARMACEUTICAL INDUSTRIES |
||
Long-term debt | ||
Notes payable, 11% |
$1,010,000 |
|
8% convertible bonds payable |
5,050,000 |
|
11% bonds payable |
5,950,000 |
|
Total long-term debt |
$12,010,000 |
|
Shareholders’ equity | ||
Preferred stock, 6% cumulative, $50 par value, 105,000 shares authorized, 26,250 shares issued and outstanding |
$1,312,500 |
|
Common stock, $1 par, 9,800,000 shares authorized, 980,000 shares issued and outstanding |
980,000 |
|
Additional paid-in capital |
3,940,000 |
|
Retained earnings |
5,910,000 |
|
Total shareholders’ equity |
$12,142,500 |
The following transactions have also occurred at Ivanhoe.
1. | Options were granted on July 1, 2016, to purchase 200,000 shares at $15 per share. Although no options were exercised during fiscal year 2017, the average price per common share during fiscal year 2017 was $20 per share. | |
2. | Each bond was issued at face value. The 8% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2016. | |
3. | The preferred stock was issued in 2016. | |
4. | There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2017. | |
5. | The 980,000 shares of common stock were outstanding for the entire 2017 fiscal year. | |
6. | Net income for fiscal year 2017 was $1,520,000, and the average income tax rate is 40%. |
For the fiscal year ended June 30, 2017, calculate the following
for Ivanhoe Pharmaceutical Industries. (Round answers
to 2 decimal places, e.g. $2.45.)
(a) Basic earnings per share.
(b) Diluted earnings per share
.
Ques 1 | |||
Basic EPS | |||
=Net income-preferrence dividends / weighted average common shares outstanding | |||
Net income | 1520000 | ||
Less:preference dividend | 78750 | ||
1312500*0.06 | |||
earnings available to common stockholders | 1441250 | ||
Weighted average common shares | 980000 | ||
EPS-Basic | $ 1.47 | per share | |
1441250/980000 | |||
Ques 2 | |||
potential dilutive securities are the convertible bonds and stock options | |||
the interest on bonds | 404000 | ||
5050000*0.08 | |||
Less:taxes | 161600 | ||
After tax amount | 242400 | ||
Bonds converted to common stock | 252500 | additional shares | |
5050000/100050 | |||
Stock options | |||
200000shares issued*15option price | 3000000 | ||
3000000total proceeds/20averagemarket price | 150000 | shares | |
200000shares issued-150000shares assumed repurchased | 50000 | icemental shares | |
So for diluted EPS we have | |||
Net income | 1520000 | ||
less:preferrence dividend | -78750 | ||
Add:interest saving | 242400 | ||
earnings available to common stockholders | 1683650 | ||
Weighted average no. of shares | |||
original | 980000 | ||
Add:new shares issued | |||
bonds | 252500 | ||
stock option | 50000 | ||
total | 1282500 | ||
Diluted EPS | |||
1683650/1282500 | $ 1.31 | PER share |